Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.13% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Edison International
EIX
$26.9B
| $208M | 0.27% |
2,659,995
-331,005
| -11% | -$26.5M |
|
52
Biogen
BIIB
$30.1B
| $207M | 0.26% |
762,861
-86,100
| -10% | -$22.8M |
|
53
American Tower
AMT
$79B
| $205M | 0.26% |
1,550,700
+281,061
| +22% | +$36M |
|
|
K
54
DELISTED
Kellanova
K
| $205M | 0.26% |
3,136,745
-226,099
| -7% | -$15.2M |
|
55
DTE Energy
DTE
$28.6B
| $204M | 0.26% |
2,270,100
+136,535
| +6% | +$12.4M |
|
56
Best Buy
BBY
$17.6B
| $202M | 0.26% |
3,528,900
+3,119,700
| +762% | +$167M |
|
57
UDR
UDR
$12B
| $199M | 0.25% |
5,113,800
+908,800
| +22% | +$34.6M |
|
58
Mid-America Apartment Communities
MAA
$15.3B
| $199M | 0.25% |
1,884,990
+451,849
| +32% | +$46.5M |
|
59
Kimberly-Clark
KMB
$36.1B
| $199M | 0.25% |
1,537,800
+546,300
| +55% | +$71.1M |
|
|
AET
60
DELISTED
Aetna Inc
AET
| $196M | 0.25% |
1,290,092
-1,821,390
| -59% | -$257M |
|
61
Entergy
ETR
$49.7B
| $195M | 0.25% |
5,068,800
-569,800
| -10% | -$22.1M |
|
62
Yum! Brands
YUM
$39.5B
| $194M | 0.25% |
2,624,500
-900
| -0% | -$62.6K |
|
63
NextEra Energy
NEE
$179B
| $193M | 0.25% |
5,500,400
-765,200
| -12% | -$26.2M |
|
64
Gaming and Leisure Properties
GLPI
$12.4B
| $192M | 0.24% |
5,086,489
+2,353,055
| +86% | +$84.3M |
|
65
O'Reilly Automotive
ORLY
$74.9B
| $189M | 0.24% |
12,929,910
+5,311,410
| +70% | +$86.7M |
|
66
Jazz Pharmaceuticals
JAZZ
$16.1B
| $187M | 0.24% |
1,201,500
+40,537
| +3% | +$6.2M |
|
67
Sherwin-Williams
SHW
$88.5B
| $186M | 0.24% |
1,593,300
-1,292,400
| -45% | -$144M |
|
68
Chipotle Mexican Grill
CMG
$40.5B
| $186M | 0.24% |
22,305,000
+14,015,000
| +169% | +$130M |
|
|
VMW
69
DELISTED
VMware, Inc
VMW
| $185M | 0.24% |
2,111,400
-49,000
| -2% | -$4.52M |
|
70
Hershey
HSY
$36.6B
| $182M | 0.23% |
1,699,400
+639,400
| +60% | +$70.5M |
|
71
Walt Disney
DIS
$179B
| $182M | 0.23% |
1,712,807
+335,207
| +24% | +$36.7M |
|
72
ServiceNow
NOW
$132B
| $181M | 0.23% |
8,540,500
+3,177,500
| +59% | +$62.3M |
|
73
Clorox
CLX
$13.1B
| $179M | 0.23% |
1,341,400
+263,700
| +24% | +$35.6M |
|
|
AIV
74
Aimco
AIV
$376M
| $175M | 0.22% |
30,573,599
+14,139,703
| +86% | +$82.5M |
|
|
ECHO
75
EchoStar
ECHO
$25.6B
| $174M | 0.22% |
3,531,437
+140,306
| +4% | +$6.69M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.